How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver. This “humanized” mouse is susceptible to human liver infections and responds to human drug treatments, providing a new way to test novel therapies for debilitating human liver diseases and other diseases with liver involvement such as malaria… (Source: Health News from Medical News Today)
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.
Further information:
Related posts:
- New horizons for studying human hepatotropic infections
- Alnylam Presents Phase I Data For ALN-VSP, An RNAi Therapeutic For The Treatment Of Liver Cancers, At ASCO Meeting
- Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis
- When Disease Can’t Be Diagnosed
- NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn’s Disease
Posted in